Inventor · disambiguated record
Xiao Zhen Zhou
Also filed as: ZHOU XIAO · ZHOU XIAO Z · ZHOU XIAO ZHEN
16 granted patents·15 pending applications·61 citations·filing 1999–2022
90Inventor score
Files withBETH ISRAEL DEACONESS MEDICAL CT INC15LU KUN PING4BETH ISRAEL HOSPITAL3DANA FARBER CANCER INST INC3CORNELL RES FOUNDATION INC1
Top patents by PatentIndex Score
31 records- 0188US8771693B2Methods and compositions for the generation and use of conformation-specific antibodiesLU KUN PING·Filed 2010·Granted Jul 8, 2014·10 cites·20 claims
- 0286US8129131B2Pin1 as a marker for abnormal cell growthLU KUN PING·Filed 2008·Granted Mar 6, 2012·14 cites·10 claims
- 0380US9688747B2Methods and compositions for the generation and use of conformation-specific antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Jun 27, 2017·4 cites·14 claims
- 0479US9968579B2ATRA for modulating Pin1 activity and stabilityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted May 15, 2018·3 cites·19 claims
- 0574US10413548B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Sep 17, 2019·1 cites·3 claims
- 0674US6495376B1Methods and compositions for regulating protein-protein interactionsBETH ISRAEL HOSPITAL·Filed 1999·Granted Dec 17, 2002·26 cites·7 claims
- 0772US10351914B2Biomarkers for Pin1-associated disordersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted Jul 16, 2019·1 cites·26 claims
- 0870US10265288B2Methods and compositions for the treatment of proliferative disordersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Apr 23, 2019·1 cites·19 claims
- 0970US9730941B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Aug 15, 2017·1 cites·3 claims
- 1070US2020291134A1Methods and compositions for the generation and use of conformation-specific antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 1163US9796784B2Methods and compositions for the generation and use of conformation-specific antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Oct 24, 2017·0 cites·20 claims
- 1262US11129835B2Methods and compositions for the inhibition of PIN1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Sep 28, 2021·0 cites·4 claims
- 1359US10485780B2Methods and compositions for the treatment of proliferative disordersLU KUN PING·Filed 2012·Granted Nov 26, 2019·0 cites·17 claims
- 1458US2018072814A1Methods and compositions for the generation and use of conformation-specific antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
- 1557US2023348578A1Conformation-specific antibodies that bind tau protein and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2021·Application pending·0 cites
- 1657US2025127783A1Inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1), combinations and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1756US2005282740A1Methods and compositions for regulating protein-protein interactionsLU KUN P·Filed 2004·Application pending·0 cites
- 1855US2025319053A1Inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1), combinations and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1954US2022348645A1Conformation-specific antibodies that bind nuclear factor kappa-light-chain-enhancer of activated b cellsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Application pending·0 cites
- 2053US2004142357A1Novel telomerase inhibitors and uses thereforBETH ISRAEL HOSPITAL·Filed 2003·Application pending·0 cites
- 2151US2003049672A1Methods and compositions for regulating protein-protein interactionsBETH ISRAEL HOSPITAL·Filed 2002·Application pending·0 cites
- 2245US2005186643A1Pin1 as a marker for abnormal cell growthFiled 2003·Application pending·0 cites
- 2343US10980835B2Arsenic trioxide for treatment of PIN1-associated disordersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Apr 20, 2021·0 cites·1 claims
- 2443US10487114B2Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereofLU KUN PING·Filed 2012·Granted Nov 26, 2019·0 cites·12 claims
- 2543US2021332024A1Modulators of pin1 activity and uses thereofYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 2642US10548864B2Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditionsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2016·Granted Feb 4, 2020·0 cites·17 claims
- 2742US2008058276A1Alzheimer's disease therapeutics based on pin-1 catalyzed conformational changes in phosphorylated amyloid precursor proteinCORNELL RES FOUNDATION INC·Filed 2007·Application pending·0 cites
- 2840US2002025521A1Pin1 as a marker for abnormal cell growthFiled 2000·Application pending·0 cites
- 2939US2021238225A1Peptidomimetic inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1)DANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3038US2017112792A1Enhanced atra-related compounds derived from structure-activity relationships and modeling for inhibiting pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Application pending·0 cites
- 3129US10017530B2Fluorination method for phosphonitrilic chloride trimer and its derivativesSHANDONG ZESHI NEW MATERIALS TECH CO LTD·Filed 2015·Granted Jul 10, 2018·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Xiao Zhen Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →